ASK YOURSELF THIS … would this message be necessary if he had an ace up his sleeve with good news coming after milestone 4 from MDT?

BelizeMe

THIS REEKS OF TOTAL DESPERATION!! LITERALLY TAGGED TO THE TOP OF THE TITAN WEBSITE

https://ir.titanmedicalinc.com/company-information/ceo-letter-to-shareholders

Software, surgeon workstation, nothing is near completion. If you believe they were "on track" in September but suddenly realized how far away they were and that they didn't know more about FDA needs earlier ... well, keep buying. Or as usual, wait for this to be below .50 cents and KEEP trying to offset delays and dilution. MDT is bailing after milestone 4 with all the goodies they needed for $10 million with no royalites.

BelizeMe

FD,

Is milestone 4 the completion of ENOS or a prototype implementing licensed IP into HUGO SP platform?

If not either, give me another scenario?

In my mind its either door #1 (completion of ENOS) or door #2 (implementing Titan IP into Hugo SP Platform).

Hugo MP platform already has a small foot print and mobile surgeon workstation, why pay money to acquire ENOS as a whole with a different workstation and software?

Medtronic needs both MP and SP platforms to work off single surgeon workstation platform for competitive and manufacturing reasons

I await you choice of door #1, door #2, or offering a third scenario

BelizeMe

Does MDT want or need ENOS?

Personally, I don't think so:

I think you are aware that Titan is developing a prototype for MDT as part of the current agreement to commmence around end of year if the latest delay on that pushed back from October is on track. So, if MDT was interested in ENOS as a whole, what is the prototype they are developing. You could say that MDT just licensed the IP just to lock it up and give Titan time to complete ENOS. So, IMO either that is the case and ENOS is still not completed to the satisfaction of MDT (at least as of Oct) or Titan is developing something else; potentially helping integrate the IP into Hugo platform? It makes sense for MDT to be able to use the same workstation platform with a Hugo MP and Hugo SP system. Acquiring ENOS as a whole does not allow that; different software and controllers, etc. Hugo MP uses individual towers so makes sense to me to for them add an SP patient tower to use with current Hugo workstation (which is already similar footprint in size and portability as the ENOS workstation. Due to timing, or lack thereof, I don't think anyone believes any of the Titan IP licensed is integrated into the CE approved Hugo MP platform so ...

I ask, where is my thinking off? Do you think Titan is developing an endoscopic solution for MDT? Highly doubtful as they can't even complete ENOS.

So I believe it leaves ONLY two scenarious:

The development agreeement in place is for:

1. MDT to help Titan complete ENOS

OR

2. Titan to integrate the licensed IP into Hugo SP platform. Sad if true as they got the IP for only $10 million and the rest of the payments were for Titan's time and engineers to integrate the IP. But remember, Titan's doors were closed and they were being sued by a vendor when MDT swooped in so you can say McNally isn't that stupid but ... guess we will find out in about six weeks (without any further delays announced)

Please tell me another scenario?????

BelizeMe

HE KNEW Just as he knew before the MULTIPLE other year delays he announced after saying “on track” each time. When you look back you can see that he showed his hand by doing a raise in between the “on track” statement and the delay statement each time, once he did back to back raises at lower and lower PPS . He did that because “HE KNEW” if would still be higher than The PPS after his delay announcement. Proof is all there if you just look back. Watch out for “bought offering” at discounted levels of these new lows before commencement of milestone 4.

BelizeMe

“If there was nothing forthcoming, it would be ENTIRELY appropriate to comment on it today, especially since they already set us up for a PPS bloodbath. It's only inappropriate to comment on it if there is SOMETHING to comment on. “

66, C’mon, seriously, McNally would never give bad news before it’s time, this time forced by quarterly reporting requirements.

Could MDT take an equity position in Titan after completing milestone 4, perhaps, but McNally would never announce MDT is out before milestone announcement.

What he did say when asked on the last call was where should the shareholders look for PPS appreciation and he said “after milestone three and four” … that leaves #4

It’s his last shot at redemption of any kind

BelizeMe

Who wants to bet. I bet MDT licensed Titan IP gets to market on an MDT product before ENOS.

Offer void if MDT miraculously takes a position in Titan

BelizeMe

nascrazy,

Let's remember this is FOUR TO FIVE YEARS OF DELAYS JUST ON DICKNALLY"S WATCH.

AFTER SAYING THEY WERE ON TRACK FOR FDA IN OCTOBER A FEW YEARS BACK, DID TWO BACK TO BACK RAISES DAY AFTER MEETING, ONLY TO ANNOUNCE FIRST OF THE YEAR THEY GOT SURGEON FEEDBACK AND NEEDED A YR TO EXPAND INDICATIONS. THEY NEW WHEN THEY SAID ON TRACK IN OCT IT WAS BS

AFTER SAYING ON TRACK TO DESIGN FREEZE AND MONTHS FROM IDE SUBMISSION THE COMPANY ALMOST HAS TO SHUT ITS DOORS AND ANNOUNCES ANOTHER YEAR DELAY AND 'OH BY THE WAY WE ARE BEING SUED BY OUR VENDORS' AND EVERYTHING WE SAID ABOUT THE ROBOT BEING ON TRACK WAS A LIE'

THINK WE ARE GONNA NEED ANOTHER YR AND BRING OUR FOCUS BACK TO GYN, YA KNOW AFTER WE SAID WE NEEDED A YR TO EXPAND INDICATIONS TWO YRS BACK

TODAYS NEWS BLAST ADDING TWO MORE YEARS

CEO OF THE CENTURY AND PROLIFIC LIAR. LOOK FOR FUTURE BOUGHT RAISES AT LOWER AND LOWER PPS AND DLUTION OF 50+% FROM HERE TO ETERNITY

KEEP SCOOPING Y'ALL, YOU KNOW DICKNALLY WILL ... WELL, HE WILL BE REWARDING HIMSELF MORE AND MORE SHARES AT LOWER PPS AND NOT INVESTING A DIME OF HIS MONEY

MDT BETTER TAKE AN EQUITY STAKE AT END OF YEAR OR THIS WILL BE AT .50, RINSE REPEAT. TWO DAILY POSTERS SAID GOING IT ALONE WOULD BE A WIN WIN.
OK THEN LOL

BELIZEME

HC,

They will never learn!! 15 yrs at best to build a SP robot the surgeons won’t use in mass due to limitations in complex surgery.

Milestone 4 now means nothing… $10 mil will be peanuts to what they will need to get this through 2025.

If MDT does not take an equity stake after milestone 4 this is toast as I’ve said before, over and over again. It will be diluted into nothingness for longs, AGAIN

BelizeMe

SMIRZA, you were right on one thing. Huge news lol. Looks like completing Enos is another couple years off, but who knows it may have another name by that point.

This management lies just as good as the last management team. Dicknally went for it on this "update", added two plus years, usually just slides in another year delay.

How much cash ya think its gonna take to get to mid 2025!! Raise, Dilution, RS … all are on the table if MDT doesn’t take an equity stake in Titan and it’s going to be on their terms at this point.

BelizeMe … cause I have been right! The cheerleaders can put their Pom Poms down and go take a cold shower. Come back at half time … that’s about mid 2024

RARELY MOVED … AFTER RETRACTED …keep up. Learn a little something.

Think it’s time for your milk and recess.

da Vinci rep. Funny.. wrong again. Haven’t done anything but device start-ups in last 15 + yrs. Don’t do big companies … too much bureaucratic BS, and they don’t pay enough.

BelizeMe

What tech is “manipulating the organs” in a 45 minute lap chole?

5 mm blunt disection and insertion of a Nathanson Liver Retractors that is locked in position after lifting the liver is standard of care … rarely move liver but can be done in 5 seconds. Any surgeon with any skill will tell you using the robot for lap chole is a joke. They could do five chole’s in a day without the robot, which provides absolutely zero clinical benefit in that case. Used for marketing purposes or ego only.

BelizeMe

You’re right. Robots are currently used in less than 15% of all lap procedures. But getting a fraction of a fraction is less valuable (2% of 15%). Simple math.

BelizeMe

First, i’ve never claimed to be a surgeon, but I interact with them almost daily, and I’ve probably been in over 1000 surgical lap procedures over my career.

I’ve been involved at the national executive level in multiple lap start-ups, including robotic arms so I have a little experience in the field with general, gyn, uro and thoracic surgery. I have worked side-by-side with US and UK surgeons who used and were consulting on lap devices I was involved in launching and had many conversations regarding single port vs multiport.

I invested in Titan when they were coming out with the multi port robot which I still wish they had been successful and proceeded vs. Enos. I’m still in this hoping for a return on my investment but was too deep in the hole due to mismanagement and dilution. I’ve averaged down and hope to get something out of this but understand the limitations on single port robot and how that will affect any valuation for a buyout. Not being able to address complex procedures, multi quadrant surgery, and having a third arm for a retraction of the liver are limitations. That’s a reality, not my opinion. Most GYN procedures can be done successfully with two arms. Most complex general surgery, urology, thoracic, cardiac procedures can not.

If people want to believe a SP robot that is used in less than 5% of all robotic cases will bring $6 to $10 B in a buyout they can
live in that world of fantasy. I will base my valuations based on the facts of what this will bring to the market and a company in that space, a complementary robot to their multi port.

None of the posters who put up these huge valuations have taken the opportunity to counter my argument. Wonder why? People just ask why am being negative lol. I’m not being negative, I’m pointing out facts.

I don’t believe there will be a buyout after the 4th milestone, and I’m hoping MDT takes a significant position in Titan. Ultimately, I think that would bring a higher PPS over the next 18 months than a buyout 2 years from FDA approval.

BelizeMe

WRONG. SP looks good to the lay person who’s never performed surgery. They think one port versus four must be better.
They don’t consider that a 2.5 cm incision near the umbilicus is ripe for a hernia down the road. Standard lap using 5mm ports don’t have this issue and don’t even have to close the fascia because of their small size and leave little to no scar.

The problem is, even with more flexible arms with Enos still can’t triangulate many angles needed in complex and multi quadrant surgery. And Enos can’t even retract the liver which required in most upper abdominal procedures.

Don’t you wonder why MAC delayed SPORT at the time for a year to expand indications in general surgery, and NOW is BACK to just targeting just GYN from the beginning?

Also, most people think robots are used in most laparoscopic procedures. They are still only used in less than 15% of all laparoscopic procedures.

BelizeMe

So sorry to point out FACTS in the real Market with the leading competitor that will affect valuation instead of throwing out ridiculously high valuations of $6-$10B that will never happen.

Been in the surgical device industry for 30 years, specifically laparoscopic start-ups for most of that time. I’ve posted many times SP is not the cure-all for robotic surgery. It has very real limits (including ENOS) on what it can do in complex and multi quadrant surgery.

In addition to those limitations Enos’s lack of a third arm limits it further as it can’t retract the liver without add’l instruments, in most cases, through an additional port.

Most on this board seem to see Enos as the next generation robot, not the next generation SP robot. BIG Difference, as SP robots are used a fraction of the time vs. multi port in both system sales and surgical volume. The revenue that a robot can bring in from capital system sales and surgical volume affects valuation of BO.

BelizeMe

(Reposted to correct typo which was too late to edit) I await responses based on facts)

Let’s break down value of SP by real world percentage of sales/usage of multi port vs SP. I tried in the past and I’ll try once more.

Intuitive SP approved in 2014. At the end of 2020 they had … wait for it, a whopping installed base of 69 SP robots. Being generous and averaging over five years vs six from 2014 to 2020 that is only 14 SP robots sold/installed per year.

With the clout, access of installed MP systems of Intuitive to expand upon and a wide open space with zero competition that is just a blip on the radar with just a fraction over 1 system PER STATE in 5 years. Hardly the $4 to 5 B in sales some are saying ENOS would bring in in the first five years.

Consider in the third quarter of 2019 Intuitive shipped 275 new da Vinci systems during the third quarter of 2019, compared to only four SP systems that were placed in operation for a total installed base of 38 at that time. That’s less than 2% of robots placed being SP!! ( I used 2019 as 2020 was not a normal sales year due to COVID)


“The da Vinci SP nicely complements the da Vinci MP systems, stated Catherine Mohr, former VP of Robot Market Strategy.” and currently President of the Intuitive Foundation.

So as some continue to value ENOS at
$6-$10 consider valuing it based on actual sales/usage vs a MP robot due to its limitations for complex and multi-quadrant procedures. Also, as stated the SP is “complementary” to the MP so rarely purchased separately as a stand-alone system that can satisfy multiple specialty needs across all levels of complexity.

In the end if Metronic was to acquire Titan and Hugo would bring in 95+ % of the revenue vs Enos what is the value for a complementary robot to Hugo? Assome will argue Enos is far better than SP
feel free to use 80/20 as the ratio. Imagine how long it would take ro recoup $6-$10 B in acquistion costs at system sales rates anywhere near these numbers? The poster putting out that sky-high valuations asked for a valid counter to their figures. Here you have it.

BelizeMe

It’s certainly one of the possibilities.

It is mind boggling that McNally let core IP go with no recurring revenue stream in case they are not acquired by MDT.

BelizeMe

Let’s break down value of SP by real world percentage of sales/usage of multi port vs SP. I tried in the past and I’ll try once more.

Intuitive SP approved in 2014. At the end of 2020 they had … wait for it, a whopping installed base of 69 SP robots. Being generous and averaging over five years vs six from 2014 to 2020 that is only 14 SP robots sold/installed per year.

With the clout, access of installed MP systems of Intuitive to expand upon and a wide open space with zero competition that is just a blip on the radar with just a fraction over 1 system PER STATE in 5 years. Hardly the $4 to 5 B in sales some are saying ENOS would bring in in the first five years.

Consider In the third quarter of 2019 Intuitive shipped 275 new da Vinci systems during the third quarter of 2019, compared to only four SP systems that were placed in operation for a total installed base of 38 at that time. That’s less than 2% of robots placed being SP!!


“The da Vinci SP nicely complements the da Vinci MP systems, stated Kathryn Mowr, VP of Robot Market Strategy.”

So as some continue to value ENOS at
$6-$10 consider valuing it based on actual sales/usage vs a MP robot due to its limitations for complex and multi-quadrant procedures. Also, as stated the SP is “complementary” to the SP so rarely purchased separately as a stand-alone system that can satisfy multiple specialty needs across all levels of complexity.

In the end if Metronic was to acquire Titan and Hugo would bring in 95+ % of the revenue vs Enos what is the value for a complementary robot to Hugo? Assome will argue Enos is far better than SP
feel free to use 80/20 as the ratio. Still not close to the sky high valuations that have been put out. The person putting out that valuation asked for a valid counter to their figures. Here you have it.

BelizeMe

Yes. Total sense. This companies doors were closed and was on the brink of bankruptcy due to mismanagement. Absolutely the only way to protect their investment and oversee the process.

BelizeMe

Martha to MDT - Hey, I just paid $41 million for IP with no protection if another company acquired the company. Unfortunately, the company was acquired and we have to give the IP back.

MDT Board - there’s the door you idiot

What a stupid thing to think any company would put themselves in that position. That would mean they would have to top any offer for Titan to keep the technology. MDT would never let themselves be put in that position by Lil’ ol Titan.

By the way, that’s also the reason they have a ton of attorneys to not let CEOs do stupid stuff like that…

BelizeMe

Don’t have to. Basic business and legal rules apply.

Do you think MDT (or any company), would enter into an agreement where Titan could sell to another company and all the work/money MDT did integrating the IP into their robot program for two years would have to come back to Titan. PLEASE. Besides legal ramifications, common sense applies…. Or at least it should, but i guess not in these days of alternative facts. Sorry, but having an opinion, or a hunch, or a feeling does not make it a fact. And not being able to see behind a redaction does not mean “anything could apply”.

BelizeMe

Anyone who posted that a new company who acquired Titan could cancel the IP license agreement in place with MDT and/or that MDT would have to give back the IP/technology if they didn’t enter into a further agreement after 4th milestone really showed their cards regarding credibility … zero

BelizeMe

Was due October … Dicknally delayed til “hopefully end of year”. He just wanted to make sure if there was a buyout it would be 2022 so people would pay higher cap gains taxes next year LOL. He’s always looking out for the retail investors.

BelizeMe

You forgot factual

BelizeMe

Not sure why you put ENOS next to link
for Medtronic hire for Hugo. Pretty misleading. This is for rolling out of Hugo not, not Enos which is not under Medtronic and is two years out … as always.

BelizeMe

This is NOT for VNOTES. It is for use with Enos in SP to aid seal while docked, maintain pneumo while also allowing insertion of ancillary instrument.

This is part of the work they did after the surgeon group told them the docking was less than optimal. Gel Port technology has been around for years.

BelizeMe

First, NEVER shorted ANY stock in my life.
Second, I NEVER said $1.18.
Third, I DID say $1.50 day of delay … and PPS hit $1.50
Fourth, the changes in submissions only mean one thing… they both were DELAYED

BelizeMe

And many others predicted $3 to $4 in September and $10 plus in October…. With the Titan delay who is further from their predictions … $1.40 and $1.18 or the $3–$4 to $10 plus crowd????

BelizeMe

Umm, Titan already announced they are starting IDE process in 2022 …. stocks at $1.53.

If Titan meets the 4th milestone with no solid expansion of agreement with $$$$ from MDT the stock will NOT be at $10-15….

It will tank as the entire market, except the “Titan can do no wrong crowd” knows how much money it would take to go it alone and the massive dilution that would ensue.

If there is SOLID CLEAR PARTNERSHIP WITH OWNERSHIP STAkE then $10-$15 is possible.

BelizeMe

Maybe in biotech/pharma for speculative medicine or a vaccine with huge potential if it got through through trials and FDA, ..not medical devices as they shouldn’t be that speculative so close to FDA.

BelizeMe

Dicknally has 2 million options/shares at low PPS. He will NEVER invest his own money and he will be comfortably set for life with any double digit BO.

BelizeMe

Send the dogs to find them!

BelizeMe

Just curious, is this ticker tracking with the QQQ LOL??

BelizeMe

Guess my $1.50 prediction the day of the milestone delay came true. Long ways from $3 to $4 dollars in September from here some were predicting. Maybe HC’s $1.40 prediction will come to pass.

I know it will just be presented it as yet ANOTHER OPPORTUNITY to scoop at unbelievably low prices …. who would have thought… well, besides me!

Long way to end of year and milestone 4 … probably lower buying opportunities coming. Hard to imagine since there is supposed to be an imminent $4-6 B buyout in the next couple of months.

BelizeMe

So it goes Up in .4 to .6 cents in the last couple minutes of trading and it’s longs buying more. When it tanks it’s the company manipulating.

If this stock had any real momentum nobody would be able to manipulate it. That would be based off results. TBD.

BelizeMe

Don’t need my help. This tanks PPS all on its own!!!

BelizeMe

Gynecological cases … yes the trend is going that way as it’s less invasive and you don’t need a secondary port to remove specimens which can be 10 to 12 mm themselves ( or enlarging existing port). For those with any knowledge of the industry they would realize that the morcellators that were the gold standard for a short period to "blend" the tissue smaller for removal for a time are no longer in use due to concerns of spreading cancer cells. Hence, large specimens need to be removed whole or cut up within a bag and then removed which is easier and safer to do vaginally. Specimens can be rock hard and up to 20+ cm.

Sorry you can’t learn this from your local auto mechanic but I provide this service free of charge. I like to bring a few facts of the board vs just Scoooop. Kind of like to $1.50 prediction that could hit as early as next week ... a far cry from the $3-4 someone (I won't say who) predicted by end of September. Wow, who'd have thought Titan "would be in the best spot they have enver been" and be at .5 cents pre-split value. Already $1.59 AH.

BelizeMe

I would never bought them but imagine if Titan actually came in on time. I remember in that scenario someone saying $3 to $4 doll run up in September and multiples of that After MDT took an actual position (not in IP) in Titan.

Guess we’ll have to wait a couple more months … again

BelizeMe

Depends on procedure and surgeon.

Sometimes robot can be very beneficial and others not necessary and would prefer skilled surgeon doing straight stick. SP robots will never fully replace MP robots. They can’t get the triangulation needed for multi quadrant complex surgeries. Also, the current da Vinci‘s use 8 mm instrument ports all around with either an 8 mm camera or 12. I prefer a surgeon using 5 mm straight stick with an HD camera and much less anesthesia time for many procedures. Then again, I’ve been in the surgical industry for over 30 years, speak daily to Gen, GYN , Uro surgeons and probably been in over 1000 surgical procedures so what do they/I know. I’m sure people in the financial and airplane industry know much more than the surgeons. The first thing people shoul learn is that a robot does not make a surgeon a better surgeon … that’s a good place to start.

BelizeMe